Monday, December 30, 2024 5:25:29 PM
Do you have anything to support the "futility halt recommendation". Seems like the trial continued.
To correct the wording, the DSMB recommended a futility finding. Per US law, the sponsor, NWBO, decides if the trial can continue. But the FDA will decide if that precludes enrollment of new patients and would issue a hold if they decide to.. As far as evidence, what we know is:
. An efficacy IA was conducted in 2015 (per the JAMA paper). NWBO disclosed it would happen, but never said a word about it later.
. The data presented at NYAS was clear that futility would be seen. It does not matter if the reason was psPD or not.
. The FDA in such a case would follow the law and allow the trial to continue if no safety issues were present. But they would not allow new enrollments as it would be unethical to have patients sign a consent (which in the trial happened at initial screening). This action by the FDA can be seen in the CVM case that was almost identical.
. Despite this being the core thesis of shorts, NWBO has never disclosed the reason despite there being no reason not to do so.
. LP is on record saying after the hold was issued that they wanted to restart enrollment "soon". If the reason was for any good news, NWBO would not say this.
Now, some dot connecting:
. NWBO went dark on the IA because even though is is legal not to disclose such, if you disclose the IA happened it can be "lying by omission" to not disclose the negative story. See the case Anders posted repeatedly where the exact issue was decided in Court.
. LP wanted the trial enrollment to resume because they were trying to change the endpoint to OS. The FDA disallowed this because the trial had already performed an IA, thus the endpoint change would still no be part of a "well run trial".
. As a factual note, NWBO implied in PRs in late 2016 that the trial was ending with planned 211(?) PFS events. Then later when that passed that it would end with 2 more OS events. Then it would end whenever. As a theory, I take it as obvious that with the trial already formally busted they were having the DSMB (or some such) perform analysis to see what was working. This would allow them to properly say the trial was still blinded despite knowing what was going on. If you doubt the legality, you can find many PRs by respected BPs that announce results while also saying the trial is ongoing and still blinded.
You can believe what you want. LP could always deny any of this, and does not.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM
FEATURED Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
